Unknown NA INTERVENTIONAL 2-arm NCT04350645

Role of Prophylactic Tranexamic Acid in Reducing Blood Loss During Elective Caesarean Section for Placenta Praevia Major

Role of Prophylactic Tranexamic Acid in Reducing Blood Loss During Elective Caesarean Section for Placenta Praevia Major: A Randomized Controlled Study

Sponsor: Universiti Kebangsaan Malaysia Medical Centre

Conditions Hemorrhage From Placenta Previa, With Delivery

Interventions Normal Saline 0.9% Tranexamic acid injection

Updated 6 times since 2020 Last updated: Jan 9, 2021 Started: Mar 24, 2020 Primary completion: Dec 23, 2021 Completion: Dec 23, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hemorrhage From Placenta Previa, With Delivery and is currently ongoing. Universiti Kebangsaan Malaysia Medical Centre leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Feb 2021 — Feb 2023 [monthly]

Recruiting NA
Jan 2021 — Feb 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

May 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universiti Kebangsaan Malaysia Medical Centre

Data source: Universiti Kebangsaan Malaysia Medical Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuala Lumpur, Malaysia